retatrutide dosing protocol Guide: 1-12 mg Weekly Triple Agonist (2026) RETATRUTIDE: THE NEXT GENERATION OF

At Harmony Aesthetics Spa, I lead every patients care, blending advanced medical treatments with real-life support

For the most current regulatory information, consult a licensed provider directly.

By drug class, the long-acting GLP-1 agonists segment held a dominant position in the market with a 63% share in 2025

4 TABLE 1 lists the FDA-approved indications for the various brands of GLP-1 and dual GIP/GLP-1 RAs

(The drug is approved by the Food and Drug Administration for weight loss under the name Wegovy.) After research demonstrated that people could lose up to 11 percent of their body weight from Ozempic, it skyrocketed in popularity as an off-label medication for weight loss

About this article Cite this article Gourdy, P., Darmon, P., Dievart, F